Cargando…
Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?
BACKGROUND: Neuroblastoma is a common solid tumor of childhood and is often associated with hypertension. Potential etiologies contributing to hypertension include renal compression, pain, volume overload, and catecholamine secretion. CASES: We completed a single center retrospective review of child...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351666/ https://www.ncbi.nlm.nih.gov/pubmed/34612613 http://dx.doi.org/10.1002/cnr2.1569 |
_version_ | 1784762483480723456 |
---|---|
author | Harding, Matthew Deyell, Rebecca J. Blydt‐Hansen, Tom |
author_facet | Harding, Matthew Deyell, Rebecca J. Blydt‐Hansen, Tom |
author_sort | Harding, Matthew |
collection | PubMed |
description | BACKGROUND: Neuroblastoma is a common solid tumor of childhood and is often associated with hypertension. Potential etiologies contributing to hypertension include renal compression, pain, volume overload, and catecholamine secretion. CASES: We completed a single center retrospective review of children with neuroblastoma and ≥stage II hypertension (per Hypertension Canada guidelines) over a 2‐year period. All patients (n = 10) had elevated urine normetanephrine levels and eight had intra‐abdominal tumors. Four patients had refractory hypertension requiring > three agents, of which three required alpha/beta blockade. CONCLUSION: Although multifactorial, hypertension in neuroblastoma often has a neuroendocrine component. Excess normetanephrine production in neuroblastoma may be a more common hypertensive mechanism than previously appreciated. Urinary normetanephrine elevation could suggest potential neuroendocrine‐mediated hypertension. |
format | Online Article Text |
id | pubmed-9351666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93516662022-08-09 Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease? Harding, Matthew Deyell, Rebecca J. Blydt‐Hansen, Tom Cancer Rep (Hoboken) Case Reports BACKGROUND: Neuroblastoma is a common solid tumor of childhood and is often associated with hypertension. Potential etiologies contributing to hypertension include renal compression, pain, volume overload, and catecholamine secretion. CASES: We completed a single center retrospective review of children with neuroblastoma and ≥stage II hypertension (per Hypertension Canada guidelines) over a 2‐year period. All patients (n = 10) had elevated urine normetanephrine levels and eight had intra‐abdominal tumors. Four patients had refractory hypertension requiring > three agents, of which three required alpha/beta blockade. CONCLUSION: Although multifactorial, hypertension in neuroblastoma often has a neuroendocrine component. Excess normetanephrine production in neuroblastoma may be a more common hypertensive mechanism than previously appreciated. Urinary normetanephrine elevation could suggest potential neuroendocrine‐mediated hypertension. John Wiley and Sons Inc. 2021-10-06 /pmc/articles/PMC9351666/ /pubmed/34612613 http://dx.doi.org/10.1002/cnr2.1569 Text en © 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Harding, Matthew Deyell, Rebecca J. Blydt‐Hansen, Tom Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease? |
title | Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease? |
title_full | Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease? |
title_fullStr | Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease? |
title_full_unstemmed | Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease? |
title_short | Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease? |
title_sort | catecholamines in neuroblastoma: driver of hypertension, or solely a marker of disease? |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351666/ https://www.ncbi.nlm.nih.gov/pubmed/34612613 http://dx.doi.org/10.1002/cnr2.1569 |
work_keys_str_mv | AT hardingmatthew catecholaminesinneuroblastomadriverofhypertensionorsolelyamarkerofdisease AT deyellrebeccaj catecholaminesinneuroblastomadriverofhypertensionorsolelyamarkerofdisease AT blydthansentom catecholaminesinneuroblastomadriverofhypertensionorsolelyamarkerofdisease |